Emmanuel Bergot

6.4k citations
121 papers · 4.8k · 3 hit papers · h-index 34

Impact in

Papers in

    • Pulmonary Hypertension Research and Treatments 23
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 22
    • Occupational and environmental lung diseases 11
    • Lung Cancer Treatments and Mutations 10
    • Lung Cancer Diagnosis and Treatment 8
    • Tuberculosis Research and Epidemiology 7

Emmanuel Bergot

114 papers receiving 4.6k citations

Emmanuel Bergot's Hit Papers

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial 2020 · 410 citations
4100+4+9Years since publication100200300400500

Peers

Emmanuel Bergot
Comparison fields: 5 of 106
  • Pulmonary and Respiratory Medicine 3.0k
  • Cardiology and Cardiovascular Medicine 935
  • Genetics 385
  • Hepatology 229
  • Hematology 319
Replace Rajan Saggar with:
Rajan Saggar United States
Pieter van Paassen Netherlands
Rajeev Saggar United States
B. Sis Canada
Philippe Guilpain France
Gilbert Massard France
Michel Delahousse France
Johannes Thaler Austria
Ami A. Shah United States
Donna J. Lager United States
Emmanuel Bergot relative to Rajan Saggar United States Rajan Saggar's profile →
Citations per field
00.5×2×4×5.2×
Rajan Saggar · 1×
Citations per year

Countries citing papers authored by Emmanuel Bergot

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Bergot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Bergot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Bergot more than expected).

Fields of papers citing papers by Emmanuel Bergot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Bergot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Bergot. The network helps show where Emmanuel Bergot may publish in the future.

Co-authors

The 25 scholars most cited alongside Emmanuel Bergot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emmanuel Bergot Line = papers co-authored together Emmanuel Bergot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Hit paper breakdown →
2017545
2
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Hit paper breakdown →
2012517
3
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Hit paper breakdown →
2020410
4 2014281
5 2020180
6 2021147
7 2000140
8 2016121
9 2017115
10 2001112
11 2014111
12 2020104
13 201296
14 201584
15 201278
16 201271
17 201971
18 202159
19 201358
20 201357

About Emmanuel Bergot

Emmanuel Bergot is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Cell Biology, Epidemiology and Oncology, having authored 121 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (23 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Occupational and environmental lung diseases (11 papers), Lung Cancer Treatments and Mutations (10 papers), Hippo pathway signaling and YAP/TAZ (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Cardiology and Cardiovascular Medicine (935 citations), Genetics (385 citations), Hepatology (229 citations) and Hematology (319 citations). Emmanuel Bergot has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Marc Humbert, Gérard ZALCMAN, Olivier SITBON, David Montani, Xavier Jaïs, Vincent Cottin, Gérald Simonneau, Guénaëlle Levallet, Arnaud Bourdin and François Picard. Their work appears in journals such as European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, The Journal of Heart and Lung Transplantation, International Journal of Cardiology and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact